» Articles » PMID: 37887695

Childbearing with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications

Overview
Publisher MDPI
Date 2023 Oct 27
PMID 37887695
Authors
Affiliations
Soon will be listed here.
Abstract

One in 20 births could be affected by hypermobile Ehlers-Danlos syndrome or Hypermobility Spectrum Disorders (hEDS/HSD); however, these are under-diagnosed and lacking research. This study aimed to examine outcomes and complications in people childbearing with hEDS/HSD. A large online international survey was completed by women with experience in childbearing and a diagnosis of hEDS/HSD ( = 947, total pregnancies = 1338). Data were collected on demographics, pregnancy and birth outcomes and complications. Participants reported pregnancies in the UK ( = 771), USA ( = 364), Australia ( = 106), Canada ( = 60), New Zealand ( = 23) and Ireland ( = 14). Incidences were higher in people with hEDS/HSD than typically found in the general population for pre-eclampsia, eclampsia, pre-term rupture of membranes, pre-term birth, antepartum haemorrhage, postpartum haemorrhage, hyperemesis gravidarum, shoulder dystocia, caesarean wound infection, postpartum psychosis, post-traumatic stress disorder, precipitate labour and being born before arrival at place of birth. This potential for increased risk related to maternal and neonatal outcomes and complications highlights the importance of diagnosis and appropriate care considerations for childbearing people with hEDS/HSD. Recommendations include updating healthcare guidance to include awareness of these possible complications and outcomes and including hEDS/HSD in initial screening questionnaires of perinatal care to ensure appropriate consultation and monitoring can take place from the start.

Citing Articles

Regulation of Joint Tissues and Joint Function: Is There Potential for Lessons to Be Learned Regarding Regulatory Control from Joint Hypermobility Syndromes?.

Hart D Int J Mol Sci. 2025; 26(3).

PMID: 39941023 PMC: 11818925. DOI: 10.3390/ijms26031256.


Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.

Pezaro S, Brock I, Buckley M, Callaway S, Demirdas S, Hakim A PLoS One. 2024; 19(5):e0302401.

PMID: 38748660 PMC: 11095771. DOI: 10.1371/journal.pone.0302401.


Co-Created Solutions for Perinatal Professionals and Childbearing Needs for People with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Pearce G, Bell L, Magee P, Pezaro S Int J Environ Res Public Health. 2023; 20(20).

PMID: 37887694 PMC: 10606217. DOI: 10.3390/ijerph20206955.

References
1.
McParlin C, ODonnell A, Robson S, Beyer F, Moloney E, Bryant A . Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review. JAMA. 2016; 316(13):1392-1401. DOI: 10.1001/jama.2016.14337. View

2.
Hakim A, Grahame R . Recognizing the scale of joint hypermobility burden: comment on the article by Mulvey et al. Arthritis Care Res (Hoboken). 2014; 66(3):496. DOI: 10.1002/acr.22221. View

3.
Kang J, Hanif M, Mirza E, Jaleel S . Ehlers-Danlos Syndrome in Pregnancy: A Review. Eur J Obstet Gynecol Reprod Biol. 2020; 255:118-123. DOI: 10.1016/j.ejogrb.2020.10.033. View

4.
Tofts L, Simmonds J, Schwartz S, Richheimer R, OConnor C, Elias E . Pediatric joint hypermobility: a diagnostic framework and narrative review. Orphanet J Rare Dis. 2023; 18(1):104. PMC: 10157984. DOI: 10.1186/s13023-023-02717-2. View

5.
Wang E, Ganti T, Vaou E, Hohler A . The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome. Allergy Asthma Proc. 2021; 42(3):243-246. DOI: 10.2500/aap.2021.42.210022. View